GIA announces the release of a comprehensive global report on Anti-hypertensive Drugs markets. The world market for anti-hypertensive drugs is projected to exceed $66.2 billion by the year 2015. This is primarily driven by a rapid rise in the number of patients suffering from high blood pressure, an aging population, and growing diagnosis and treatment rates. Angiotensin II blockers represent the largest class of drug in terms of revenue generation among the five major classes of drugs used for the treatment of hypertension.

Read the full story at http://www.prweb.com/releases/anti_hypertensive_drugs/blood_pressure_medicines/prweb3453394.htm